Coldstream Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
4,728
-2,093
-31% -$93.5K ﹤0.01% 1176
2026
Q1
$329K Sell
6,821
-3,310
-33% -$154K ﹤0.01% 888
2025
Q4
$491K Buy
10,131
+978
+11% +$48.5K 0.01% 735
2025
Q3
$432K Sell
9,153
-4,006
-30% -$193K 0.01% 802
2025
Q2
$636K Buy
13,159
+6,210
+89% +$317K 0.01% 559
2025
Q1
$385K Buy
6,949
+1,430
+26% +$77.4K 0.01% 724
2024
Q4
$266K Sell
5,519
-562
-9% -$28.6K 0.01% 883
2024
Q3
$350K Buy
6,081
+866
+17% +$46.8K 0.01% 761
2024
Q2
$253K Sell
5,215
-88
-2% -$4.25K 0.01% 832
2024
Q1
$258K Buy
+5,303
New +$259K 0.01% 832

Other funds holding SNY

Coldstream Capital Management's SNY Position: Q2 2026 in Review

Coldstream Capital Management reduced its Sanofi (SNY) stake by 31% in Q2 2026, selling an estimated $93.5K and leaving 4,728 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1176.

Coldstream Capital Management first reported a position in SNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $636K in Q2 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Coldstream Capital Management held 4,728 shares of Sanofi worth $202K as of Q2 2026.
  • Coldstream Capital Management sold 2,093 Sanofi shares in Q2 2026, an estimated $93.5K.
  • Sanofi made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1176 holding.
  • Coldstream Capital Management first reported a position in Sanofi in Q1 2024 and has held it in 10 quarters since.
  • Coldstream Capital Management's Sanofi position peaked at $636K in Q2 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.